North America Nuclear Imaging Equipment Market Outlook to 2033 - Positron Emission Tomography (PET) Systems, Single Photon Emission Computed Tomography (SPECT) Systems and Others

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Nuclear Imaging Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Nuclear Imaging Equipment Market, North America, Revenue ($m), 2018-2033
3.2 Nuclear Imaging Equipment Market, North America, Revenue ($m), 2018-2033
3.3 Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
3.4 Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
3.5 Nuclear Imaging Equipment Market, North America, Company Share by Revenue ($m), 2024

4.1 Nuclear Imaging Equipment Market, Canada, Revenue ($m), 2018-2033
4.2 Nuclear Imaging Equipment Market, Canada, Volume (Units), 2018-2033
4.3 Nuclear Imaging Equipment Market, Canada, Average Price ($), 2018-2033
4.4 Nuclear Imaging Equipment Market, Canada, Company Share by Revenue ($m), 2024

5.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2018-2033
5.2 Nuclear Imaging Equipment Market, United States, Volume (Units), 2018-2033
5.3 Nuclear Imaging Equipment Market, United States, Average Price ($), 2018-2033
5.4 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2024

6.1 Nuclear Imaging Equipment Market, Mexico, Revenue ($m), 2018-2033
6.2 Nuclear Imaging Equipment Market, Mexico, Volume (Units), 2018-2033
6.3 Nuclear Imaging Equipment Market, Mexico, Average Price ($), 2018-2033
6.4 Nuclear Imaging Equipment Market, Mexico, Company Share by Revenue ($m), 2024

7.1 Siemens Healthineers AG
7.1.1 Company Overview
7.2 GE HealthCare Technologies Inc
7.2.1 Company Overview
7.3 Shanghai United Imaging Healthcare Co Ltd
7.3.1 Company Overview
7.4 Canon Medical Systems Corp
7.4.1 Company Overview

9.1 Corporate Communications
9.1.1 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant
9.2 Financial Announcements
9.2.1 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025
9.2.2 Feb 26, 2025: Humacyte Announces Commercial Launch of Symvess (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
9.2.3 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
9.2.4 Nov 12, 2024: Oxford Instruments Announces Half-Year Results
9.3 Government and Public Interest
9.3.1 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
9.3.2 Aug 23, 2024: Nurexone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
9.4 Legal And Regulatory
9.4.1 Jul 01, 2025: Shenzhen Wikkon Precision Instruments Receives 510(K) Clearance For U200 Extracorporeal Shock Wave Lithotripter
9.5 Product News
9.5.1 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 the analyst Consulting
10.3 Contact the Publisher
10.4 Disclaimer

Table 1: Nuclear Imaging Equipment Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Nuclear Imaging Equipment Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
Table 4: Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
Table 5: Nuclear Imaging Equipment Market, North America, Company Share by Revenue ($m), 2024
Table 1: Nuclear Imaging Equipment Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 6: Nuclear Imaging Equipment Market, Canada, Volume (Units), 2018-2033
Table 7: Nuclear Imaging Equipment Market, Canada, Average Price ($), 2018-2033
Table 8: Nuclear Imaging Equipment Market, Canada, Company Share by Revenue ($m), 2024
Table 9: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 10: Nuclear Imaging Equipment Market, United States, Volume (Units), 2018-2033
Table 11: Nuclear Imaging Equipment Market, United States, Average Price ($), 2018-2033
Table 12: Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2024
Table 13: Nuclear Imaging Equipment Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 14: Nuclear Imaging Equipment Market, Mexico, Volume (Units), 2018-2033
Table 15: Nuclear Imaging Equipment Market, Mexico, Average Price ($), 2018-2033
Table 16: Nuclear Imaging Equipment Market, Mexico, Company Share by Revenue ($m), 2024
Table 17: Nuclear Imaging Equipment Market Pipeline Products
Table 18: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country

Figure 1: Nuclear Imaging Equipment Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Nuclear Imaging Equipment Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
Figure 4: Nuclear Imaging Equipment Market, North America, Volume (Units), 2018-2033
Figure 5: Nuclear Imaging Equipment Market, North America, Company Share (%), 2024
Figure 6: Nuclear Imaging Equipment Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Nuclear Imaging Equipment Market, Canada, Volume (Units), 2018-2033
Figure 8: Nuclear Imaging Equipment Market, Canada, Company Share (%), 2024
Figure 9: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 10: Nuclear Imaging Equipment Market, United States, Volume (Units), 2018-2033
Figure 11: Nuclear Imaging Equipment Market, United States, Company Share (%), 2024
Figure 12: Nuclear Imaging Equipment Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 13: Nuclear Imaging Equipment Market, Mexico, Volume (Units), 2018-2033
Figure 14: Nuclear Imaging Equipment Market, Mexico, Company Share (%), 2024